Literature DB >> 26974661

C/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4.

Bruno Di Stefano1,2, Samuel Collombet3, Janus Schou Jakobsen4,5,6, Michael Wierer7, Jose Luis Sardina1,2, Andreas Lackner1,2, Ralph Stadhouders1,2, Carolina Segura-Morales1,2, Mirko Francesconi1,2, Francesco Limone1,2, Matthias Mann7, Bo Porse4,5,6, Denis Thieffry3, Thomas Graf1,2.   

Abstract

Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) is typically inefficient and has been explained by elite-cell and stochastic models. We recently reported that B cells exposed to a pulse of C/EBPα (Bα' cells) behave as elite cells, in that they can be rapidly and efficiently reprogrammed into iPSCs by the Yamanaka factors OSKM. Here we show that C/EBPα post-transcriptionally increases the abundance of several hundred proteins, including Lsd1, Hdac1, Brd4, Med1 and Cdk9, components of chromatin-modifying complexes present at super-enhancers. Lsd1 was found to be required for B cell gene silencing and Brd4 for the activation of the pluripotency program. C/EBPα also promotes chromatin accessibility in pluripotent cells and upregulates Klf4 by binding to two haematopoietic enhancers. Bα' cells share many properties with granulocyte/macrophage progenitors, naturally occurring elite cells that are obligate targets for leukaemic transformation, whose formation strictly requires C/EBPα.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974661     DOI: 10.1038/ncb3326

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  68 in total

1.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

2.  H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs.

Authors:  Jiekai Chen; He Liu; Jing Liu; Jing Qi; Bei Wei; Jiaqi Yang; Hanquan Liang; You Chen; Jing Chen; Yaran Wu; Lin Guo; Jieying Zhu; Xiangjie Zhao; Tianran Peng; Yixin Zhang; Shen Chen; Xuejia Li; Dongwei Li; Tao Wang; Duanqing Pei
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330

3.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation.

Authors:  Benoit Laurent; Lv Ruitu; Jernej Murn; Kristina Hempel; Ryan Ferrao; Yang Xiang; Shichong Liu; Benjamin A Garcia; Hao Wu; Feizhen Wu; Hanno Steen; Yang Shi
Journal:  Mol Cell       Date:  2015-02-12       Impact factor: 17.970

5.  CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation.

Authors:  Alessandro Di Tullio; Thien Phong Vu Manh; Alexis Schubert; Giancarlo Castellano; Robert Månsson; Thomas Graf
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

6.  The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.

Authors:  Yadi Wu; Yifan Wang; Xiuwei H Yang; Tiebang Kang; Yongxiang Zhao; Chi Wang; B Mark Evers; Binhua P Zhou
Journal:  Cell Rep       Date:  2013-09-26       Impact factor: 9.423

7.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 8.  Transcriptional regulation of early B cell development.

Authors:  Daniel L Northrup; David Allman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 9.  Mechanisms and models of somatic cell reprogramming.

Authors:  Yosef Buganim; Dina A Faddah; Rudolf Jaenisch
Journal:  Nat Rev Genet       Date:  2013-06       Impact factor: 53.242

10.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

View more
  29 in total

1.  C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.

Authors:  Wei Chen; Guochun Zhu; Jun Tang; Hou-De Zhou; Yi-Ping Li
Journal:  J Pathol       Date:  2018-01-29       Impact factor: 7.996

Review 2.  Chromatin accessibility dynamics during cell fate reprogramming.

Authors:  Dongwei Li; Xiaodong Shu; Ping Zhu; Duanqing Pei
Journal:  EMBO Rep       Date:  2021-01-22       Impact factor: 8.807

3.  Logical modeling of lymphoid and myeloid cell specification and transdifferentiation.

Authors:  Samuel Collombet; Chris van Oevelen; Jose Luis Sardina Ortega; Wassim Abou-Jaoudé; Bruno Di Stefano; Morgane Thomas-Chollier; Thomas Graf; Denis Thieffry
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-06       Impact factor: 11.205

4.  Constitutively active SMAD2/3 facilitates efficient transcription factor-mediated cell conversion.

Authors:  Sophia Kelaini; Andriana Margariti
Journal:  Stem Cell Investig       Date:  2018-08-22

5.  Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.

Authors:  Mohammad S Makki; Tariq M Haqqi
Journal:  Connect Tissue Res       Date:  2016-07-12       Impact factor: 3.417

6.  Nascent Induced Pluripotent Stem Cells Efficiently Generate Entirely iPSC-Derived Mice while Expressing Differentiation-Associated Genes.

Authors:  Bhishma Amlani; Yiyuan Liu; Taotao Chen; Ly-Sha Ee; Peter Lopez; Adriana Heguy; Effie Apostolou; Sang Yong Kim; Matthias Stadtfeld
Journal:  Cell Rep       Date:  2018-01-28       Impact factor: 9.423

7.  Monocyte-Specific Knockout of C/ebpα Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebpα in Osteoclast Differentiation and Function.

Authors:  Wei Chen; Guochun Zhu; Joel Jules; Diep Nguyen; Yi-Ping Li
Journal:  J Bone Miner Res       Date:  2018-01-26       Impact factor: 6.741

8.  Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion.

Authors:  Yan Xiu; Qianze Dong; Lin Fu; Aaron Bossler; Xiaobing Tang; Brendan Boyce; Nicholas Borcherding; Mariah Leidinger; José Luis Sardina; Hai-Hui Xue; Qingchang Li; Andrew Feldman; Iannis Aifantis; Francesco Boccalatte; Lili Wang; Meiling Jin; Joseph Khoury; Wei Wang; Shimin Hu; Youzhong Yuan; Endi Wang; Ji Yuan; Siegfried Janz; John Colgan; Hasem Habelhah; Thomas Waldschmidt; Markus Müschen; Adam Bagg; Benjamin Darbro; Chen Zhao
Journal:  Blood       Date:  2020-01-09       Impact factor: 22.113

9.  Discovery of [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Novel LSD1 Inhibitors.

Authors:  Zhong-Hua Li; Xue-Qi Liu; Peng-Fei Geng; Feng-Zhi Suo; Jin-Lian Ma; Bin Yu; Tao-Qian Zhao; Zhao-Qing Zhou; Chen-Xi Huang; Yi-Chao Zheng; Hong-Min Liu
Journal:  ACS Med Chem Lett       Date:  2017-03-06       Impact factor: 4.345

Review 10.  Bromodomain 4: a cellular Swiss army knife.

Authors:  Ballachanda N Devaiah; Anne Gegonne; Dinah S Singer
Journal:  J Leukoc Biol       Date:  2016-07-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.